EQS for diclofenac not justified, say UK experts

A UK scientific committee has questioned the adoption of an environmental quality standards for the drug and substances used in contraceptive pills

The adoption of an environmental quality standard (EQS) for anti-inflammatory drug diclofenac under EU water legislation is not justified because the data available appears to be unreliable, a UK scientific committee has warned.

In a letter to British minister Richard Benyon, the Hazardous Substances Advisory Committee (HSAC) explained there are "significant issues on water solubility… which may invalidate many of the tests" carried out.

Please sign in to access this article. To subscribe, view our subscription options, or take out a free trial.

Please enter your details

Forgotten password?

Having trouble signing in?

Contact Customer Support at
or call 020 8267 8120

Not a subscriber?

Take a free trial now to discover the critical insights and updates our coverage offers subscribers.